Auto1-MS1

Obe-cel in Refractory Progressive Forms of Multiple Sclerosis

Condition(s)

  • Multiple sclerosis

Project type

  • Clinical drug trial

About the project

This phase 1 clinical trial is designed to establish the tolerability, safety, and preliminary efficacy of obe-cel in participants with refractory progressive multiple sclerosis.  

Funder(s)

Autolus Limited UK
The logo for Autolus for the Auto1-MS1 clinical trial

Status

Closed for recruitment at this site

Contact

Jill Hunter, Senior Research Nurse

0131 465 9517

Eligibility criteria

Complex eligibility criteria apply, please get in touch for more details.

×